Carola A S. Arndt, M.D., is intimately involved in the design of new clinical trials to improve the cure rate of pediatric sarcoma. She is also on the national Children's Oncology Group soft tissue sarcoma committee and bone tumor committee.
- Bone sarcoma
Significance to patient care
New clinical studies on sarcomas aim to decrease the burden of cure — late effects of therapy — for those patients whose prognosis is good, while aiming to increase the cure rate using novel therapies for those intermediate- and high-risk patients who do not have a high cure rate.
- Executive Committee, Children's Oncology Group
- Pediatric Oncology Subcommittee, Oncologic Drugs Advisory Committee, Food and Drug Administration